EGF and non-small cell lung carcinoma: In addition, the statistical tests applied with the same three molecules used for NSCLC (sEGFR, EGF and TGF-α) allowed a correct discrimination of 97.6% of the healthy donors and 100% of the HNC patients by DA and 100% of the healthy donors and 100% of the HNC patients by LR.